Tweets
2017 US life expectancy decreased for the 3rd year in a row. Drug overdoses & suicides lead the trend, resulting in earlier deaths and how long people live. Life expectancy dropped 78.7 yrs in 2016 to 78.6 yrs in 2017, with changes in men; not women https://t.co/gUParIkR6W
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 8 months ago
Dont Miss the Next Best Meeting in Rheumatology - RHEUMNOW LIVE - March 22-24 2019 in beautiful downtown Fort Worth. Short Lectures, interactive sessions, Q&A panels, TED (like) Talks, digital, streaming and much more. You dont want to miss this meeting! https://t.co/5TVg0Frsbf
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 8 months ago
The RheumNow Podcast is Up! To Needle or Not to Needle; Watch https://t.co/pjYZh5LXzi or listent to the weekly news and review https://t.co/AmXgjki2dL
Dr. John Cush @RheumNow ( View Tweet )
7 years 8 months ago
296 women with HTN during pregnancy (half/147 NSAID-exposed) - NSAID use was not associated with a significant change in BP (vs no NSAID) and there was no added need to start or increase BP meds in those on NSAIDS. https://t.co/csDljBJI3r
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 8 months ago
AstraZeneca today announced the FDA has granted Orphan Drug Status for Fasenra (benralizumab) for Eosinophilic Granulomatosis with Polyangiitis (EGPA). Fasenra is also approved for severe, eosinophilic asthma https://t.co/4ChX8D5Evx
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 8 months ago
Cohort VAMC study shows that Diabetes management (A1C, LDL, HTN) (n=368,481 patients) and outcomes were the same between physicians (n 3487), nurse practitioners (1445) and physician assistants (443). https://t.co/ToNVcPrMZN
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 8 months ago
Amyotrophic lateral sclerosis, AKA Lou Gehrig’s dz (ALS), a progressive/fatal neuromuscular dz has an estimated prevalence of 5.2 per 100,000 - with a total of 16,583 cases identified. The majority of ALS patients die within 2–5 years of a diagnosis. https://t.co/Yg7aIspfnN
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 8 months ago
What’s Next in Biosimilars is one of several educational videos available in the "Therapeutic Update: Biosimilars in Rheumatology" video series, sponsored by Sandoz, Inc. and now available on RheumNow. https://t.co/1vmnEJqOSi
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 8 months ago
UK's NHS has spent £400million on Humira for 46,000 UK patients and starting in December will replace it with biosimilars of adalimumab at a cost of £100million https://t.co/jYzHi2pxrB
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 8 months ago
Study of 2053 RA patients from VA medical centers found 27% with chronic lung disease that confered a 51% increased mortality risk that was not altered by MTX or biologic therapy. https://t.co/nYFnScSXQ4
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 8 months ago
Amongst 192 patients w/ ANCA Assoc. vasculitis there were 95 severe infections (25%; 26/100PYs). TMP/SMX prophylaxis lowered risk of severe infections by 70% (HR 0.30). Risk was higher w/ age, bronchiectasis, endobronchial dz, COPD. https://t.co/aDEGNuwsEH
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 8 months ago
FDA has approved Genentechs ACTpen - a tocilizumab autoinjector 162 mg sc for use in RA, GCA, poly & systemic JIA - should be available in January 2019. https://t.co/YzFHyYxQlS
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 8 months ago
A systematic literature review shows that triple positivity for ACPAs, RF, and anti‐CarP antibodies yields a higher specificity for RA (98–100%), accompanied by a lower sensitivity (11–39%). https://t.co/TKAZd7CP1M
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 8 months ago
Claims data study from Germany looked at OA of hip or knee in adults > 60 yrs finding 595,754 pts (mean 75 yrs; 70% female) Dx with OA (21.8%); 63% received analgesics, higher with increasing age. PT in 43.1% and 5.3% w/ joint replacement in 2014. https://t.co/shLSlDeO9h
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 8 months ago
CDC review of new syndrome Acute Flaccid Myelitis - 106 cases in 2018, mostly white (86%), children (median 4 yrs) w/ rapid onset of flaccid weakness in one or more limbs and spinal cord gray matter lesions. Evidence suggests a viral association. https://t.co/C5FHAHMHI9
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 8 months ago
